HB 484 — Maryland
Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising
No summary was supplied with the source record. Read the full text below.
Latest action: Hearing 2/12 at 1:00 p.m. · Jan 23, 2026
Status label is derived from the recorded actions. The full text below is the record.
Updated Mar 17, 2026
Timeline
First Reading Ways and Means
Jan 23, 2026 · House of Delegates
Hearing 2/12 at 1:00 p.m.
Jan 23, 2026 · House of Delegates
Sponsored by Natalie Ziegler, Jessica Feldmark, Jen Terrasa, Jackie Addison, Lorig Charkoudian, Bonnie Cullison, Eric Ebersole, Pam Guzzone, Terri Hill, Gabriel Moreno, Courtney Watson
No recorded floor votes yet.
Official records. Maryland legislators, bills and roll-call votes from the Maryland General Assembly, imported through Open States on Oct 27, 2026 (trial import — not the full session). Accuracy review against the official site is still under way. Campaign-finance records for Maryland are not imported yet.